Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,658,407
+$1,400,598 QoQ
Shares Held
31,649
+334.1% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#190
of 421 holders
Holding Since
Dec 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bridgefront Capital, LLC holds $2,674,930 across 3 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (62.0% of the industry book) .
All Filings in ALKS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,658,407 | 31,649 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $257,809 | 7,291 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $206,520 | 7,381 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $770,884 | 23,346 | Shares | Sole | 2025-05-15 | |
| 2021-06-30 | $333,398 | 13,597 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $449,074 | 22,510 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||